MedPath

Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) Patients

Terminated
Conditions
Asthma
Chronic Obstructive Pulmonary Disease
Interstitial Lung Disease
Interventions
Procedure: Capnography
Registration Number
NCT00744614
Lead Sponsor
Lahey Clinic
Brief Summary

The purpose of this study is to evaluate the use of Capnography (Continuous recording of the carbon dioxide content of expired air)as an alternative test to measure PC02 levels in patients with asthma, chronic obstructive pulmonary (COPD,interstitial lung disease(ILD)or coronary disease who are at risk of intubation.

Detailed Description

This is a prospective study to evaluate the usefulness of capnography as a non-invasive, accurate method of measuring of PC02 levels in medical intensive care unit patients with asthma, COPD, ILD, or coronary disease who are at risk of intubation.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Medical Intensive Care Patients
  • Not intubated
  • Age 18 or older
  • History of any one of the following: asthma, COPD, ILD, or coronary disease
Exclusion Criteria
  • Sepsis
  • Life expectancy less than 1 month
  • Requiring BIPAP

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1CapnographyMedical Intensive care unit patients with asthma, COPD, ILD or coronary disease who are at risk of intubation
Primary Outcome Measures
NameTimeMethod
PCO2 level6 months
Secondary Outcome Measures
NameTimeMethod
Time to intubation6 months

Trial Locations

Locations (1)

Lahey Clinic, Inc.

🇺🇸

Burlington, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath